Profile data is unavailable for this security.
About the company
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.
- Revenue in USD (TTM)3.47bn
- Net income in USD630.00m
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|ILMN:NSQ since |
|GRAIL Inc||Announced||21 Sep 2020||21 Sep 2020Announced||67.77%||8.00bn|